Urinary Bladder, Overactive

26 competing products in clinical development for Urinary Bladder, Overactive.

Pipeline by Phase

Pre-clinical3
Phase 11
Phase 22
Phase 317
Approved3

All Products (26)

ProductCompanyStageStatusHype
SolifenacinAstellas PharmaApprovedCompleted
43
Alpha blocker + placebo + solifenacinAstellas PharmaApprovedCompleted
43
Placebo + Solifenacin SuccinateAstellas PharmaApprovedCompleted
43
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3Completed
40
solifenacin succinateAstellas PharmaPhase 3Completed
40
solifenacin succinate + tolterodineAstellas PharmaPhase 3Completed
40
Solifenacin succinate + TolterodineAstellas PharmaPhase 3Completed
40
Solifenacin succinate + PlaceboAstellas PharmaPhase 3Completed
40
Mirabegron + PlaceboAstellas PharmaPhase 3Completed
40
Solifenacin succinate + Mirabegron + Placebo to match solifenacin succinate + Placebo to match mirabegronAstellas PharmaPhase 3Completed
40
YM178Astellas PharmaPhase 3Completed
40
YM178 + Placebo + tolterodineAstellas PharmaPhase 3Completed
40
YM178 + Placebo + tolterodine ERAstellas PharmaPhase 3Completed
40
Mirabegron + PlaceboAstellas PharmaPhase 3Completed
40
Solifenacin Succinate Suspension + PlaceboAstellas PharmaPhase 3Completed
40
Mirabegron + Tolterodine + Placebo to Mirabegron + Placebo to TolterodineAstellas PharmaPhase 3Completed
40
VESIcare® + placeboAstellas PharmaPhase 3Completed
40
Solifenacin succinate suspensionAstellas PharmaPhase 3Completed
40
Solifenacin succinate + Mirabegron + Placebo to match solifenacin + Placebo to match mirabegronAstellas PharmaPhase 3Completed
40
solifenacin succinateAstellas PharmaPhase 3Completed
40
YM178 + PlaceboAstellas PharmaPhase 2Completed
35
YM178 + tolterodine + PlaceboAstellas PharmaPhase 2Completed
35
Solifenacin succinate suspension 2.5 mg + Solifenacin succinate suspension 5 mg + Solifenacin succinate suspension 10 mgAstellas PharmaPhase 1Completed
29
SolifenacinAstellas PharmaPre-clinicalCompleted
26
SolifenacinAstellas PharmaPre-clinicalCompleted
26
mirabegron + antimuscarinic medicationAstellas PharmaPre-clinicalCompleted
26